Drugs News and Research

RSS

Scientists decode genome of Streptococcus sanguinis

Virginia Commonwealth University researchers have decoded the genome of a bacteria normally present in the healthy human mouth that can cause a deadly heart infection if it enters the bloodstream.

7 Apr 2007

Cylindrical nanoparticles deliver drugs to tumors

Researchers at the University of Pennsylvania School of Medicine & School of Engineering and Applied Science have discovered a better way to deliver drugs to tumors.

7 Apr 2007

Largest-ever Parkinson's disease trials

Researchers with the National Institute of Neurological Disorders and Stroke (NINDS) have initiated one of the largest-ever Parkinson's disease clinical trials.

7 Apr 2007

Environmental factors in the development of Parkinson's disease

The Parkinson's Institute today announced that new findings concerning the role of environmental factors in the development of Parkinson's disease will be reported at Asilomar (Pacific Grove, CA) as part of the final meeting of the Collaborative Centers for Parkinson's Disease Environmental Research (CCPDER).

7 Apr 2007

New role for sugars on proteins

In a ground-breaking study published in the top journal, Cell, Dr. James Dennis, senior investigator at the Samuel Lunenfeld Research Institute at Mount Sinai Hospital, has discovered a new role for sugars on proteins.

7 Apr 2007

Ibuprofen interferes with the blood thinning properties of aspirin in patients at high risk for cardiovascular disease

Doctors who treat the painful condition of osteoarthritis in patients with increased cardiovascular risk need to be cautious.

7 Apr 2007

$1.1 billion funding to low-income individuals living with HIV/AIDS in U.S.

HHS Secretary Mike Leavitt has announced more than $1.1 billion in funding to help states and territories provide care, medications and services for low-income individuals living with HIV/AIDS.

7 Apr 2007

New findings on salicylates may lead to more effective aspirin-like drugs

Salicylates, including aspirin, are used to treat a range of inflammatory conditions and can be used to prevent diseases such as cancer, but the way aspirin works is not yet fully understood.

7 Apr 2007

Alteon expands agreement with Biorap Technologies

Alteon has announced that it has entered into an expanded licensing agreement with BioRap Technologies, the commercialization arm of the Rappaport Family Institute for Research, Technion University, Israel, for all diagnostic devices or products for predictive purposes in vascular or cardiac diseases, including diagnostic assays for the measurement of the haptoglobin protein (Hp).

7 Apr 2007

Lower doses of dexamethasone for multiple myeloma recommended

The International Myeloma Foundation (IMF) - supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians - today said physicians should consider lowering the dose of the steroid dexamethasone when treating patients with multiple myeloma.

5 Apr 2007

Theatre is an educational tool in the fight against illicit drugs

A new study finds that theatrical drama is an educational tool in the fight against drug addiction and abuse.

5 Apr 2007

Pharmacyclics undergoes 'file over protest' for Xcytrin NDA

Pharmacyclics, Inc. has announced its request to the U.S. Food and Drug Administration (FDA) that its New Drug Application (NDA) for Xcytrin (motexafin gadolinium) Injection be filed over protest.

5 Apr 2007

Market study into the distribution of medicines in the UK

The OFT has launched a market study into the distribution of medicines in the UK. This decision follows recent and proposed distribution changes by leading UK medicine suppliers.

5 Apr 2007

Serious side effects from large amounts of niacin

Taking excessive doses of a common vitamin in an attempt to defeat drug screening tests may send the user to the hospital -- or worse.

5 Apr 2007

Nicotine shown to enhance learning and memory

While nicotine is highly addictive, researchers have also shown the drug to enhance learning and memory, a property that has launched efforts to develop nicotine-like drugs to treat cognitive deficits in Alzheimer's and Parkinson's diseases, schizophrenia, and attention-deficit/hyperactivity disorder.

5 Apr 2007

iIbuprofen may increase likelihood of heart problems in osteoarthritis patients

The common painkiller, ibuprofen, may boost the likelihood of heart problems in high risk patients who have osteoarthritis, suggests research published ahead of print in the Annals of the Rheumatic Diseases.

5 Apr 2007

Many US multiple sclerosis patients aren't receiving the latest drug therapies

Immunomodulatory agents (IMAs) could slow the progress of the disease, but are only prescribed in a minority of cases, and mostly by neurologists.

5 Apr 2007

Overcoming denial of medical conditions

Denial is a common response to a stressful situation. It can be an important coping and defense mechanism. But it also can delay the appropriate response to circumstances that require action and change.

5 Apr 2007

How auxin regulates TIR1 in plants provides clues to new treatments for human diseases

For the first time, scientists from the University of Washington School of Medicine, Indiana University Bloomington and the University of Cambridge have determined how a plant hormone -- auxin -- interacts with its hormone receptor, called TIR1.

5 Apr 2007

AARP asks U.S. Senator Coleman to stand up to big pharma

AARP State President Skip Humphrey stood with a group of red-shirted AARP members and representatives of the Minnesota Senior Federation and the Elder Care Rights Alliance to urge U.S. Senator Norm Coleman to support legislation to give Medicare the authority to negotiate with drug companies for lower prescription drug prices.

5 Apr 2007